✦ LIBER ✦

Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomib

✍ Scribed by Jiri Minarik; Vlastimil Scudla; Marta Ordeltova; Jaroslav Bacovsky; Tomas Pika; Katerina Langova

Book ID: 114794646
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 248 KB
Volume: 83
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2009.01321.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P140 Prognostic impact of 1q21 amplifica

P140 Prognostic impact of 1q21 amplification in patients with multiple myeloma treated by velcade, thalidomide and any conventional chemotherapy

✍ P. Nemec; P. Kuglik; V. Vranova; R. Zaoralova; H. Greslikova; A. Oltova; H. Filk 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Conclusions: Among their pts with GI nHl the slow increase of incidence from all lymphoma cases, the slight decrease of MALT lymphomas, the elevation of cases of intestinal and of gastric lymphomas with high grade B-cell origin and at all, in this latter group the beneficial effect of rituximab+CHOP

Updated survivals and prognostic factor

Updated survivals and prognostic factor analysis in myeloma treated by a staged approach use of bortezomib/thalidomide/dexamethasone in transplant eligible patients

✍ Chor Sang Chim 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 690 KB

Circulating angiopoietin-1 to angiopoiet

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

✍ Evangelos Terpos; Konstantinos Anargyrou; Eirini Katodritou; Efstathios Kastriti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

## Abstract The circulating levels of several angiogenic cytokines [angiopoietin‐1 (Ang‐1), angiopoietin‐2 (Ang‐2), vascular endothelial growth factor (VEGF), angiogenin and basic fibroblast growth factor (bFGF)] were evaluated in 174 consecutive patients with newly diagnosed, symptomatic, multiple